Israel Cancer Research Fund Inc

Analysis

Israel Cancer Research Fund Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in February 1976, 50 years ago. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Israel Cancer Research Fund Inc reported income of $7.7m and spending of $6.4m, spending 82% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $7.7m to $7.7m (+0.1%), an average of +0.0% a year. The sharpest change came in the year to December 2021, when income rose by 52%. Over the whole period it spent 85% of the income it received.

Among 72,936 United States charities whose main cause is other charitable purposes and that reported income, Israel Cancer Research Fund Inc sits at the 94th percentile: it is larger than about 94% of them. Against every charity in United States with reported income it ranks in the 94th percentile, and in the 92nd percentile within NY. Charities of a similar size with the same main cause include Catholic Charities North Dakota ($7.7m), Good Samaritan Home Inc ($7.7m) and Sauder Village ($7.7m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 101% of the total. Compensation of current officers, directors and key employees was $1.1m (17% of expenses). Other salaries and wages came to $806k. At year end it held assets of $19.3m against liabilities of $3.3m, net assets of $16.0m. It reported 12 employees.